nodes	percent_of_prediction	percent_of_DWPC	metapath
Calcitriol—GC—prostate gland—urinary bladder cancer	0.0286	0.127	CbGeAlD
Calcitriol—CYP24A1—prostate gland—urinary bladder cancer	0.0239	0.106	CbGeAlD
Calcitriol—CYP24A1—seminal vesicle—urinary bladder cancer	0.0202	0.0897	CbGeAlD
Calcitriol—GC—renal system—urinary bladder cancer	0.0195	0.0868	CbGeAlD
Calcitriol—CYP24A1—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.0184	0.0578	CbGpPWpGaD
Calcitriol—CYP24A1—renal system—urinary bladder cancer	0.0163	0.0723	CbGeAlD
Calcitriol—GC—female reproductive system—urinary bladder cancer	0.0156	0.0695	CbGeAlD
Calcitriol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.0139	0.0436	CbGpPWpGaD
Calcitriol—VDR—prostate gland—urinary bladder cancer	0.0131	0.0584	CbGeAlD
Calcitriol—CYP24A1—female reproductive system—urinary bladder cancer	0.013	0.0579	CbGeAlD
Calcitriol—CYP3A4—urine—urinary bladder cancer	0.0122	0.0544	CbGeAlD
Calcitriol—CYP24A1—vagina—urinary bladder cancer	0.0118	0.0524	CbGeAlD
Calcitriol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.0117	0.0366	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—KRT5—urinary bladder cancer	0.01	0.0313	CbGpPWpGaD
Calcitriol—VDR—epithelium—urinary bladder cancer	0.00966	0.0429	CbGeAlD
Calcitriol—VDR—renal system—urinary bladder cancer	0.00896	0.0398	CbGeAlD
Calcitriol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00884	0.0277	CbGpPWpGaD
Calcitriol—VDR—urethra—urinary bladder cancer	0.0088	0.0391	CbGeAlD
Calcitriol—CYP24A1—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00872	0.0273	CbGpPWpGaD
Calcitriol—Calcipotriol—MPO—urinary bladder cancer	0.00728	1	CrCbGaD
Calcitriol—VDR—female reproductive system—urinary bladder cancer	0.00717	0.0319	CbGeAlD
Calcitriol—CYP24A1—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00717	0.0225	CbGpPWpGaD
Calcitriol—VDR—vagina—urinary bladder cancer	0.00649	0.0288	CbGeAlD
Calcitriol—CYP3A4—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.00639	0.02	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—TP63—urinary bladder cancer	0.00606	0.019	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—TP63—urinary bladder cancer	0.00542	0.017	CbGpPWpGaD
Calcitriol—VDR—Ovarian Infertility Genes—ESR2—urinary bladder cancer	0.00521	0.0163	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—GSTZ1—urinary bladder cancer	0.00488	0.0153	CbGpPWpGaD
Calcitriol—CYP24A1—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00481	0.0151	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—IGFBP3—urinary bladder cancer	0.00476	0.0149	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—GSTO2—urinary bladder cancer	0.00462	0.0145	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—NAT1—urinary bladder cancer	0.00462	0.0145	CbGpPWpGaD
Calcitriol—CYP24A1—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00456	0.0143	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptors—ESR2—urinary bladder cancer	0.00454	0.0142	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—IGFBP3—urinary bladder cancer	0.00426	0.0133	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—UGT2B7—urinary bladder cancer	0.00423	0.0132	CbGpPWpGaD
Calcitriol—VDR—lymph node—urinary bladder cancer	0.0042	0.0187	CbGeAlD
Calcitriol—CYP24A1—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00417	0.0131	CbGpPWpGaD
Calcitriol—VDR—Ovarian Infertility Genes—NCOR1—urinary bladder cancer	0.00402	0.0126	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—CYP4B1—urinary bladder cancer	0.00381	0.0119	CbGpPWpGaD
Calcitriol—CYP24A1—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00375	0.0118	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—JAG1—urinary bladder cancer	0.00364	0.0114	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.00359	0.0112	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—NQO1—urinary bladder cancer	0.00345	0.0108	CbGpPWpGaD
Calcitriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—PPARG—urinary bladder cancer	0.00341	0.0107	CbGpPWpGaD
Calcitriol—CYP3A4—Estrogen metabolism—UGT2B7—urinary bladder cancer	0.00334	0.0105	CbGpPWpGaD
Calcitriol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.00328	0.0103	CbGpPWpGaD
Calcitriol—VDR—Ovarian Infertility Genes—ATM—urinary bladder cancer	0.00319	0.00999	CbGpPWpGaD
Calcitriol—VDR—Ovarian Infertility Genes—CDK4—urinary bladder cancer	0.00317	0.00995	CbGpPWpGaD
Calcitriol—CYP3A4—renal system—urinary bladder cancer	0.00299	0.0133	CbGeAlD
Calcitriol—CYP3A4—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.00295	0.00925	CbGpPWpGaD
Calcitriol—VDR—Retinoic acid receptors-mediated signaling—CREBBP—urinary bladder cancer	0.00292	0.00914	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptors—ESR1—urinary bladder cancer	0.00276	0.00863	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.00275	0.00861	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00274	0.00858	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—NAT2—urinary bladder cancer	0.00253	0.00794	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—TP63—urinary bladder cancer	0.00253	0.00793	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptors—PPARG—urinary bladder cancer	0.00251	0.00788	CbGpPWpGaD
Calcitriol—CYP24A1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.0025	0.00783	CbGpPWpGaD
Calcitriol—CYP3A4—female reproductive system—urinary bladder cancer	0.0024	0.0107	CbGeAlD
Calcitriol—CYP3A4—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.00239	0.0075	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—FAS—urinary bladder cancer	0.00237	0.00744	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—ATM—urinary bladder cancer	0.00234	0.00735	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptor transcription pathway—ESR1—urinary bladder cancer	0.00218	0.00682	CbGpPWpGaD
Calcitriol—CYP3A4—Aflatoxin B1 metabolism—GSTM1—urinary bladder cancer	0.0021	0.00659	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—HPGDS—urinary bladder cancer	0.00202	0.00634	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—IGFBP3—urinary bladder cancer	0.00199	0.00623	CbGpPWpGaD
Calcitriol—VDR—Retinoic acid receptors-mediated signaling—EP300—urinary bladder cancer	0.00199	0.00623	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.00199	0.00622	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—GSTT1—urinary bladder cancer	0.00196	0.00615	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—NCOR1—urinary bladder cancer	0.00191	0.006	CbGpPWpGaD
Calcitriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TNF—urinary bladder cancer	0.00181	0.00567	CbGpPWpGaD
Calcitriol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.00181	0.00566	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—urinary bladder cancer	0.00178	0.00559	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—CDKN2A—urinary bladder cancer	0.0016	0.005	CbGpPWpGaD
Calcitriol—GC—Metabolism—GSTZ1—urinary bladder cancer	0.00156	0.00489	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—CDK4—urinary bladder cancer	0.00151	0.00473	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—ESR1—urinary bladder cancer	0.0015	0.00471	CbGpPWpGaD
Calcitriol—GC—Metabolism—GSTO2—urinary bladder cancer	0.00148	0.00464	CbGpPWpGaD
Calcitriol—GC—Metabolism—NAT1—urinary bladder cancer	0.00148	0.00464	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00146	0.00458	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.00146	0.00456	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—GSTP1—urinary bladder cancer	0.00136	0.00426	CbGpPWpGaD
Calcitriol—GC—Metabolism—UGT2B7—urinary bladder cancer	0.00135	0.00424	CbGpPWpGaD
Calcitriol—CYP24A1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00134	0.00421	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—CREBBP—urinary bladder cancer	0.00132	0.00413	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—CDKN1A—urinary bladder cancer	0.0013	0.00409	CbGpPWpGaD
Calcitriol—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.00129	0.00404	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—GSTM1—urinary bladder cancer	0.00125	0.00392	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—EP300—urinary bladder cancer	0.00124	0.00389	CbGpPWpGaD
Calcitriol—CYP24A1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00123	0.00387	CbGpPWpGaD
Calcitriol—GC—Metabolism—CYP4B1—urinary bladder cancer	0.00122	0.00382	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—GPX1—urinary bladder cancer	0.00118	0.00371	CbGpPWpGaD
Calcitriol—GC—Metabolism—SLC19A1—urinary bladder cancer	0.00115	0.00361	CbGpPWpGaD
Calcitriol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00115	0.00359	CbGpPWpGaD
Calcitriol—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00113	0.00355	CbGpPWpGaD
Calcitriol—GC—Metabolism—PRSS3—urinary bladder cancer	0.00112	0.00352	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—FAS—urinary bladder cancer	0.00111	0.00347	CbGpPWpGaD
Calcitriol—Hypertension—Thiotepa—urinary bladder cancer	0.00109	0.00242	CcSEcCtD
Calcitriol—Arrhythmia—Gemcitabine—urinary bladder cancer	0.00109	0.00242	CcSEcCtD
Calcitriol—Phosphatase alkaline increased—Doxorubicin—urinary bladder cancer	0.00107	0.00239	CcSEcCtD
Calcitriol—Myalgia—Thiotepa—urinary bladder cancer	0.00107	0.00239	CcSEcCtD
Calcitriol—Arrhythmia—Fluorouracil—urinary bladder cancer	0.00107	0.00238	CcSEcCtD
Calcitriol—Anxiety—Thiotepa—urinary bladder cancer	0.00107	0.00238	CcSEcCtD
Calcitriol—Erythema—Gemcitabine—urinary bladder cancer	0.00106	0.00236	CcSEcCtD
Calcitriol—Erythema—Fluorouracil—urinary bladder cancer	0.00104	0.00232	CcSEcCtD
Calcitriol—Polyuria—Methotrexate—urinary bladder cancer	0.00102	0.00228	CcSEcCtD
Calcitriol—Arrhythmia—Cisplatin—urinary bladder cancer	0.00101	0.00226	CcSEcCtD
Calcitriol—Blood urea increased—Doxorubicin—urinary bladder cancer	0.00101	0.00226	CcSEcCtD
Calcitriol—Skin disorder—Thiotepa—urinary bladder cancer	0.000997	0.00222	CcSEcCtD
Calcitriol—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000988	0.00309	CbGpPWpGaD
Calcitriol—Erythema—Cisplatin—urinary bladder cancer	0.000986	0.0022	CcSEcCtD
Calcitriol—Erythema multiforme—Etoposide—urinary bladder cancer	0.000981	0.00219	CcSEcCtD
Calcitriol—Anorexia—Thiotepa—urinary bladder cancer	0.000978	0.00218	CcSEcCtD
Calcitriol—Blood alkaline phosphatase increased—Epirubicin—urinary bladder cancer	0.000967	0.00215	CcSEcCtD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.000943	0.00296	CbGpPWpGaD
Calcitriol—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.000935	0.00208	CcSEcCtD
Calcitriol—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00093	0.00291	CbGpPWpGaD
Calcitriol—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000926	0.0029	CbGpPWpGaD
Calcitriol—Hypertension—Gemcitabine—urinary bladder cancer	0.000913	0.00204	CcSEcCtD
Calcitriol—Somnolence—Thiotepa—urinary bladder cancer	0.000912	0.00203	CcSEcCtD
Calcitriol—Convulsion—Fluorouracil—urinary bladder cancer	0.000901	0.00201	CcSEcCtD
Calcitriol—Chest pain—Gemcitabine—urinary bladder cancer	0.0009	0.00201	CcSEcCtD
Calcitriol—Myalgia—Gemcitabine—urinary bladder cancer	0.0009	0.00201	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000899	0.00282	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.000898	0.00281	CbGpPWpGaD
Calcitriol—GC—Metabolism—TYMP—urinary bladder cancer	0.000897	0.00281	CbGpPWpGaD
Calcitriol—Blood alkaline phosphatase increased—Doxorubicin—urinary bladder cancer	0.000894	0.00199	CcSEcCtD
Calcitriol—Decreased appetite—Thiotepa—urinary bladder cancer	0.000892	0.00199	CcSEcCtD
Calcitriol—Discomfort—Gemcitabine—urinary bladder cancer	0.00089	0.00198	CcSEcCtD
Calcitriol—Chest pain—Fluorouracil—urinary bladder cancer	0.000885	0.00197	CcSEcCtD
Calcitriol—Myalgia—Fluorouracil—urinary bladder cancer	0.000885	0.00197	CcSEcCtD
Calcitriol—Dysgeusia—Etoposide—urinary bladder cancer	0.000884	0.00197	CcSEcCtD
Calcitriol—Dermatitis bullous—Epirubicin—urinary bladder cancer	0.00088	0.00196	CcSEcCtD
Calcitriol—Constipation—Thiotepa—urinary bladder cancer	0.000878	0.00196	CcSEcCtD
Calcitriol—Pain—Thiotepa—urinary bladder cancer	0.000878	0.00196	CcSEcCtD
Calcitriol—Discomfort—Fluorouracil—urinary bladder cancer	0.000875	0.00195	CcSEcCtD
Calcitriol—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000863	0.00192	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000861	0.0027	CbGpPWpGaD
Calcitriol—Convulsion—Cisplatin—urinary bladder cancer	0.000854	0.0019	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—CREBBP—urinary bladder cancer	0.000851	0.00267	CbGpPWpGaD
Calcitriol—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000849	0.00189	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—RB1—urinary bladder cancer	0.000848	0.00266	CbGpPWpGaD
Calcitriol—Pain in extremity—Epirubicin—urinary bladder cancer	0.000841	0.00187	CcSEcCtD
Calcitriol—Myalgia—Cisplatin—urinary bladder cancer	0.000839	0.00187	CcSEcCtD
Calcitriol—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000839	0.00187	CcSEcCtD
Calcitriol—Skin disorder—Gemcitabine—urinary bladder cancer	0.000838	0.00187	CcSEcCtD
Calcitriol—Anxiety—Cisplatin—urinary bladder cancer	0.000836	0.00186	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—GSTZ1—urinary bladder cancer	0.000834	0.00261	CbGpPWpGaD
Calcitriol—Discomfort—Cisplatin—urinary bladder cancer	0.000829	0.00185	CcSEcCtD
Calcitriol—Anorexia—Gemcitabine—urinary bladder cancer	0.000823	0.00183	CcSEcCtD
Calcitriol—Urticaria—Thiotepa—urinary bladder cancer	0.000815	0.00182	CcSEcCtD
Calcitriol—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.000814	0.00181	CcSEcCtD
Calcitriol—Body temperature increased—Thiotepa—urinary bladder cancer	0.000811	0.00181	CcSEcCtD
Calcitriol—Abdominal pain—Thiotepa—urinary bladder cancer	0.000811	0.00181	CcSEcCtD
Calcitriol—GC—Metabolism—NAT2—urinary bladder cancer	0.000811	0.00254	CbGpPWpGaD
Calcitriol—Anorexia—Fluorouracil—urinary bladder cancer	0.000809	0.0018	CcSEcCtD
Calcitriol—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000805	0.00179	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—GSTO2—urinary bladder cancer	0.00079	0.00248	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—NAT1—urinary bladder cancer	0.00079	0.00248	CbGpPWpGaD
Calcitriol—Blood creatinine increased—Epirubicin—urinary bladder cancer	0.000788	0.00176	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000786	0.00175	CcSEcCtD
Calcitriol—Convulsion—Etoposide—urinary bladder cancer	0.000783	0.00174	CcSEcCtD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	0.000782	0.00245	CbGpPWpGaD
Calcitriol—Dehydration—Epirubicin—urinary bladder cancer	0.000782	0.00174	CcSEcCtD
Calcitriol—Skin disorder—Cisplatin—urinary bladder cancer	0.000782	0.00174	CcSEcCtD
Calcitriol—Insomnia—Gemcitabine—urinary bladder cancer	0.000781	0.00174	CcSEcCtD
Calcitriol—Hypertension—Etoposide—urinary bladder cancer	0.00078	0.00174	CcSEcCtD
Calcitriol—Pain in extremity—Doxorubicin—urinary bladder cancer	0.000778	0.00173	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000777	0.00244	CbGpPWpGaD
Calcitriol—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000773	0.00172	CcSEcCtD
Calcitriol—Chest pain—Etoposide—urinary bladder cancer	0.000769	0.00171	CcSEcCtD
Calcitriol—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.000768	0.00171	CcSEcCtD
Calcitriol—Insomnia—Fluorouracil—urinary bladder cancer	0.000768	0.00171	CcSEcCtD
Calcitriol—Somnolence—Gemcitabine—urinary bladder cancer	0.000767	0.00171	CcSEcCtD
Calcitriol—Anorexia—Cisplatin—urinary bladder cancer	0.000767	0.00171	CcSEcCtD
Calcitriol—Pancreatitis—Methotrexate—urinary bladder cancer	0.000761	0.0017	CcSEcCtD
Calcitriol—Discomfort—Etoposide—urinary bladder cancer	0.00076	0.00169	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	0.000757	0.00169	CcSEcCtD
Calcitriol—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000756	0.00169	CcSEcCtD
Calcitriol—Somnolence—Fluorouracil—urinary bladder cancer	0.000755	0.00168	CcSEcCtD
Calcitriol—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.000752	0.00168	CcSEcCtD
Calcitriol—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00075	0.00167	CcSEcCtD
Calcitriol—Pain—Gemcitabine—urinary bladder cancer	0.000738	0.00165	CcSEcCtD
Calcitriol—Constipation—Gemcitabine—urinary bladder cancer	0.000738	0.00165	CcSEcCtD
Calcitriol—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000738	0.00164	CcSEcCtD
Calcitriol—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000737	0.00164	CcSEcCtD
Calcitriol—Asthenia—Thiotepa—urinary bladder cancer	0.000736	0.00164	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000733	0.00163	CcSEcCtD
Calcitriol—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.000729	0.00162	CcSEcCtD
Calcitriol—Pruritus—Thiotepa—urinary bladder cancer	0.000726	0.00162	CcSEcCtD
Calcitriol—Pain—Fluorouracil—urinary bladder cancer	0.000726	0.00162	CcSEcCtD
Calcitriol—Dehydration—Doxorubicin—urinary bladder cancer	0.000723	0.00161	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—UGT2B7—urinary bladder cancer	0.000723	0.00227	CbGpPWpGaD
Calcitriol—Skin disorder—Etoposide—urinary bladder cancer	0.000716	0.0016	CcSEcCtD
Calcitriol—Pancreatitis—Epirubicin—urinary bladder cancer	0.000712	0.00159	CcSEcCtD
Calcitriol—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.00071	0.00158	CcSEcCtD
Calcitriol—Anorexia—Etoposide—urinary bladder cancer	0.000703	0.00157	CcSEcCtD
Calcitriol—Diarrhoea—Thiotepa—urinary bladder cancer	0.000702	0.00157	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.0007	0.00156	CcSEcCtD
Calcitriol—GC—Metabolism—RRM2—urinary bladder cancer	0.0007	0.00219	CbGpPWpGaD
Calcitriol—Decreased appetite—Cisplatin—urinary bladder cancer	0.000699	0.00156	CcSEcCtD
Calcitriol—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.000696	0.00155	CcSEcCtD
Calcitriol—Drowsiness—Methotrexate—urinary bladder cancer	0.000692	0.00154	CcSEcCtD
Calcitriol—Pain—Cisplatin—urinary bladder cancer	0.000688	0.00153	CcSEcCtD
Calcitriol—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000682	0.00152	CcSEcCtD
Calcitriol—Urticaria—Fluorouracil—urinary bladder cancer	0.000674	0.0015	CcSEcCtD
Calcitriol—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000673	0.0015	CcSEcCtD
Calcitriol—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000671	0.0015	CcSEcCtD
Calcitriol—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000659	0.00147	CcSEcCtD
Calcitriol—Weight decreased—Epirubicin—urinary bladder cancer	0.000657	0.00147	CcSEcCtD
Calcitriol—Somnolence—Etoposide—urinary bladder cancer	0.000655	0.00146	CcSEcCtD
Calcitriol—Vomiting—Thiotepa—urinary bladder cancer	0.000652	0.00145	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—CYP4B1—urinary bladder cancer	0.000651	0.00204	CbGpPWpGaD
Calcitriol—GC—Metabolism—HPGDS—urinary bladder cancer	0.000648	0.00203	CbGpPWpGaD
Calcitriol—GC—Metabolism—ENO2—urinary bladder cancer	0.000648	0.00203	CbGpPWpGaD
Calcitriol—Drowsiness—Epirubicin—urinary bladder cancer	0.000648	0.00144	CcSEcCtD
Calcitriol—Rash—Thiotepa—urinary bladder cancer	0.000647	0.00144	CcSEcCtD
Calcitriol—Dermatitis—Thiotepa—urinary bladder cancer	0.000646	0.00144	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000645	0.00202	CbGpPWpGaD
Calcitriol—Headache—Thiotepa—urinary bladder cancer	0.000643	0.00143	CcSEcCtD
Calcitriol—Decreased appetite—Etoposide—urinary bladder cancer	0.000641	0.00143	CcSEcCtD
Calcitriol—Body temperature increased—Cisplatin—urinary bladder cancer	0.000636	0.00142	CcSEcCtD
Calcitriol—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000633	0.00198	CbGpPWpGaD
Calcitriol—Pain—Etoposide—urinary bladder cancer	0.00063	0.00141	CcSEcCtD
Calcitriol—Constipation—Etoposide—urinary bladder cancer	0.00063	0.00141	CcSEcCtD
Calcitriol—Conjunctivitis—Epirubicin—urinary bladder cancer	0.00063	0.0014	CcSEcCtD
Calcitriol—Urinary tract infection—Epirubicin—urinary bladder cancer	0.00063	0.0014	CcSEcCtD
Calcitriol—GC—Metabolism—GSTT1—urinary bladder cancer	0.000629	0.00197	CbGpPWpGaD
Calcitriol—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000625	0.00139	CcSEcCtD
Calcitriol—Haemoglobin—Methotrexate—urinary bladder cancer	0.000625	0.00139	CcSEcCtD
Calcitriol—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000624	0.00196	CbGpPWpGaD
Calcitriol—Haemorrhage—Methotrexate—urinary bladder cancer	0.000621	0.00139	CcSEcCtD
Calcitriol—VDR—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.00062	0.00194	CbGpPWpGaD
Calcitriol—Asthenia—Gemcitabine—urinary bladder cancer	0.000619	0.00138	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000619	0.00194	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—SLC19A1—urinary bladder cancer	0.000615	0.00193	CbGpPWpGaD
Calcitriol—Pruritus—Gemcitabine—urinary bladder cancer	0.000611	0.00136	CcSEcCtD
Calcitriol—Nausea—Thiotepa—urinary bladder cancer	0.00061	0.00136	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—CDKN1A—urinary bladder cancer	0.000609	0.00191	CbGpPWpGaD
Calcitriol—Weight decreased—Doxorubicin—urinary bladder cancer	0.000608	0.00136	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—PTEN—urinary bladder cancer	0.000608	0.0019	CbGpPWpGaD
Calcitriol—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000603	0.00134	CcSEcCtD
Calcitriol—Pruritus—Fluorouracil—urinary bladder cancer	0.0006	0.00134	CcSEcCtD
Calcitriol—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.0006	0.00188	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.0006	0.00188	CbGpPWpGaD
Calcitriol—Drowsiness—Doxorubicin—urinary bladder cancer	0.000599	0.00134	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—PRSS3—urinary bladder cancer	0.000599	0.00188	CbGpPWpGaD
Calcitriol—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000593	0.00132	CcSEcCtD
Calcitriol—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000592	0.00185	CbGpPWpGaD
Calcitriol—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000591	0.00132	CcSEcCtD
Calcitriol—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000588	0.00131	CcSEcCtD
Calcitriol—Urticaria—Etoposide—urinary bladder cancer	0.000586	0.00131	CcSEcCtD
Calcitriol—Haemoglobin—Epirubicin—urinary bladder cancer	0.000585	0.0013	CcSEcCtD
Calcitriol—Abdominal pain—Etoposide—urinary bladder cancer	0.000583	0.0013	CcSEcCtD
Calcitriol—Body temperature increased—Etoposide—urinary bladder cancer	0.000583	0.0013	CcSEcCtD
Calcitriol—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000583	0.0013	CcSEcCtD
Calcitriol—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000583	0.0013	CcSEcCtD
Calcitriol—Haemorrhage—Epirubicin—urinary bladder cancer	0.000582	0.0013	CcSEcCtD
Calcitriol—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000581	0.00129	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—EP300—urinary bladder cancer	0.000579	0.00182	CbGpPWpGaD
Calcitriol—Asthenia—Cisplatin—urinary bladder cancer	0.000577	0.00129	CcSEcCtD
Calcitriol—Diarrhoea—Cisplatin—urinary bladder cancer	0.000551	0.00123	CcSEcCtD
Calcitriol—Erythema multiforme—Epirubicin—urinary bladder cancer	0.00055	0.00123	CcSEcCtD
Calcitriol—Vomiting—Gemcitabine—urinary bladder cancer	0.000549	0.00122	CcSEcCtD
Calcitriol—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000549	0.00172	CbGpPWpGaD
Calcitriol—Rash—Gemcitabine—urinary bladder cancer	0.000544	0.00121	CcSEcCtD
Calcitriol—Dermatitis—Gemcitabine—urinary bladder cancer	0.000544	0.00121	CcSEcCtD
Calcitriol—Hypersensitivity—Etoposide—urinary bladder cancer	0.000543	0.00121	CcSEcCtD
Calcitriol—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000541	0.0017	CbGpPWpGaD
Calcitriol—Erythema—Methotrexate—urinary bladder cancer	0.000541	0.00121	CcSEcCtD
Calcitriol—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000541	0.00121	CcSEcCtD
Calcitriol—Headache—Gemcitabine—urinary bladder cancer	0.000541	0.00121	CcSEcCtD
Calcitriol—Vomiting—Fluorouracil—urinary bladder cancer	0.00054	0.0012	CcSEcCtD
Calcitriol—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000538	0.0012	CcSEcCtD
Calcitriol—Rash—Fluorouracil—urinary bladder cancer	0.000535	0.00119	CcSEcCtD
Calcitriol—Dermatitis—Fluorouracil—urinary bladder cancer	0.000535	0.00119	CcSEcCtD
Calcitriol—Headache—Fluorouracil—urinary bladder cancer	0.000532	0.00119	CcSEcCtD
Calcitriol—Dysgeusia—Methotrexate—urinary bladder cancer	0.00053	0.00118	CcSEcCtD
Calcitriol—Asthenia—Etoposide—urinary bladder cancer	0.000529	0.00118	CcSEcCtD
Calcitriol—GC—Metabolism—NQO1—urinary bladder cancer	0.000523	0.00164	CbGpPWpGaD
Calcitriol—Pruritus—Etoposide—urinary bladder cancer	0.000521	0.00116	CcSEcCtD
Calcitriol—Arrhythmia—Epirubicin—urinary bladder cancer	0.00052	0.00116	CcSEcCtD
Calcitriol—Nausea—Gemcitabine—urinary bladder cancer	0.000513	0.00114	CcSEcCtD
Calcitriol—Vomiting—Cisplatin—urinary bladder cancer	0.000512	0.00114	CcSEcCtD
Calcitriol—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000509	0.00113	CcSEcCtD
Calcitriol—Rash—Cisplatin—urinary bladder cancer	0.000507	0.00113	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000507	0.00159	CbGpPWpGaD
Calcitriol—Dermatitis—Cisplatin—urinary bladder cancer	0.000507	0.00113	CcSEcCtD
Calcitriol—Erythema—Epirubicin—urinary bladder cancer	0.000506	0.00113	CcSEcCtD
Calcitriol—Diarrhoea—Etoposide—urinary bladder cancer	0.000504	0.00112	CcSEcCtD
Calcitriol—Nausea—Fluorouracil—urinary bladder cancer	0.000504	0.00112	CcSEcCtD
Calcitriol—Dysgeusia—Epirubicin—urinary bladder cancer	0.000496	0.00111	CcSEcCtD
Calcitriol—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000494	0.00155	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—EGFR—urinary bladder cancer	0.000494	0.00155	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000487	0.00153	CbGpPWpGaD
Calcitriol—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000481	0.00107	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.00048	0.0015	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—TYMP—urinary bladder cancer	0.000479	0.0015	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000479	0.0015	CbGpPWpGaD
Calcitriol—Nausea—Cisplatin—urinary bladder cancer	0.000478	0.00107	CcSEcCtD
Calcitriol—Convulsion—Methotrexate—urinary bladder cancer	0.000469	0.00104	CcSEcCtD
Calcitriol—Vomiting—Etoposide—urinary bladder cancer	0.000469	0.00104	CcSEcCtD
Calcitriol—Erythema—Doxorubicin—urinary bladder cancer	0.000468	0.00104	CcSEcCtD
Calcitriol—Agitation—Epirubicin—urinary bladder cancer	0.000465	0.00104	CcSEcCtD
Calcitriol—Rash—Etoposide—urinary bladder cancer	0.000465	0.00104	CcSEcCtD
Calcitriol—Dermatitis—Etoposide—urinary bladder cancer	0.000464	0.00103	CcSEcCtD
Calcitriol—Headache—Etoposide—urinary bladder cancer	0.000462	0.00103	CcSEcCtD
Calcitriol—Myalgia—Methotrexate—urinary bladder cancer	0.000461	0.00103	CcSEcCtD
Calcitriol—Chest pain—Methotrexate—urinary bladder cancer	0.000461	0.00103	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.00046	0.00144	CbGpPWpGaD
Calcitriol—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000459	0.00102	CcSEcCtD
Calcitriol—Discomfort—Methotrexate—urinary bladder cancer	0.000455	0.00101	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000442	0.00139	CbGpPWpGaD
Calcitriol—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000442	0.000984	CcSEcCtD
Calcitriol—Convulsion—Epirubicin—urinary bladder cancer	0.000439	0.000978	CcSEcCtD
Calcitriol—Nausea—Etoposide—urinary bladder cancer	0.000438	0.000976	CcSEcCtD
Calcitriol—Hypertension—Epirubicin—urinary bladder cancer	0.000437	0.000974	CcSEcCtD
Calcitriol—GC—Metabolism—GSTP1—urinary bladder cancer	0.000436	0.00137	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—NAT2—urinary bladder cancer	0.000433	0.00136	CbGpPWpGaD
Calcitriol—Chest pain—Epirubicin—urinary bladder cancer	0.000431	0.000961	CcSEcCtD
Calcitriol—Myalgia—Epirubicin—urinary bladder cancer	0.000431	0.000961	CcSEcCtD
Calcitriol—Agitation—Doxorubicin—urinary bladder cancer	0.00043	0.00096	CcSEcCtD
Calcitriol—Anxiety—Epirubicin—urinary bladder cancer	0.00043	0.000957	CcSEcCtD
Calcitriol—Skin disorder—Methotrexate—urinary bladder cancer	0.000429	0.000956	CcSEcCtD
Calcitriol—Discomfort—Epirubicin—urinary bladder cancer	0.000426	0.000949	CcSEcCtD
Calcitriol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000425	0.00133	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000422	0.00132	CbGpPWpGaD
Calcitriol—Dry mouth—Epirubicin—urinary bladder cancer	0.000422	0.00094	CcSEcCtD
Calcitriol—Anorexia—Methotrexate—urinary bladder cancer	0.000421	0.000938	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—TP53—urinary bladder cancer	0.000415	0.0013	CbGpPWpGaD
Calcitriol—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000413	0.000921	CcSEcCtD
Calcitriol—Convulsion—Doxorubicin—urinary bladder cancer	0.000406	0.000905	CcSEcCtD
Calcitriol—GC—Metabolism—TYMS—urinary bladder cancer	0.000405	0.00127	CbGpPWpGaD
Calcitriol—Hypertension—Doxorubicin—urinary bladder cancer	0.000404	0.000901	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000402	0.000897	CcSEcCtD
Calcitriol—Skin disorder—Epirubicin—urinary bladder cancer	0.000401	0.000895	CcSEcCtD
Calcitriol—GC—Metabolism—GSTM1—urinary bladder cancer	0.000401	0.00126	CbGpPWpGaD
Calcitriol—GC—Metabolism—NCOR1—urinary bladder cancer	0.000401	0.00126	CbGpPWpGaD
Calcitriol—Insomnia—Methotrexate—urinary bladder cancer	0.000399	0.00089	CcSEcCtD
Calcitriol—Myalgia—Doxorubicin—urinary bladder cancer	0.000399	0.000889	CcSEcCtD
Calcitriol—Chest pain—Doxorubicin—urinary bladder cancer	0.000399	0.000889	CcSEcCtD
Calcitriol—Anxiety—Doxorubicin—urinary bladder cancer	0.000397	0.000886	CcSEcCtD
Calcitriol—Discomfort—Doxorubicin—urinary bladder cancer	0.000394	0.000878	CcSEcCtD
Calcitriol—Anorexia—Epirubicin—urinary bladder cancer	0.000394	0.000878	CcSEcCtD
Calcitriol—Somnolence—Methotrexate—urinary bladder cancer	0.000393	0.000875	CcSEcCtD
Calcitriol—Dry mouth—Doxorubicin—urinary bladder cancer	0.00039	0.000869	CcSEcCtD
Calcitriol—Decreased appetite—Methotrexate—urinary bladder cancer	0.000384	0.000856	CcSEcCtD
Calcitriol—GC—Metabolism—GPX1—urinary bladder cancer	0.000384	0.0012	CbGpPWpGaD
Calcitriol—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000382	0.000852	CcSEcCtD
Calcitriol—Pain—Methotrexate—urinary bladder cancer	0.000378	0.000842	CcSEcCtD
Calcitriol—GC—Metabolism—ERCC2—urinary bladder cancer	0.000377	0.00118	CbGpPWpGaD
Calcitriol—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000376	0.000839	CcSEcCtD
Calcitriol—VDR—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000376	0.00118	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—RRM2—urinary bladder cancer	0.000374	0.00117	CbGpPWpGaD
Calcitriol—Insomnia—Epirubicin—urinary bladder cancer	0.000374	0.000833	CcSEcCtD
Calcitriol—Skin disorder—Doxorubicin—urinary bladder cancer	0.000371	0.000828	CcSEcCtD
Calcitriol—Somnolence—Epirubicin—urinary bladder cancer	0.000367	0.000819	CcSEcCtD
Calcitriol—Anorexia—Doxorubicin—urinary bladder cancer	0.000364	0.000812	CcSEcCtD
Calcitriol—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000361	0.000805	CcSEcCtD
Calcitriol—Decreased appetite—Epirubicin—urinary bladder cancer	0.000359	0.000801	CcSEcCtD
Calcitriol—GC—Metabolism—MTHFR—urinary bladder cancer	0.000354	0.00111	CbGpPWpGaD
Calcitriol—Pain—Epirubicin—urinary bladder cancer	0.000353	0.000788	CcSEcCtD
Calcitriol—Constipation—Epirubicin—urinary bladder cancer	0.000353	0.000788	CcSEcCtD
Calcitriol—Urticaria—Methotrexate—urinary bladder cancer	0.000351	0.000782	CcSEcCtD
Calcitriol—Body temperature increased—Methotrexate—urinary bladder cancer	0.000349	0.000778	CcSEcCtD
Calcitriol—Abdominal pain—Methotrexate—urinary bladder cancer	0.000349	0.000778	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000348	0.000776	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—ENO2—urinary bladder cancer	0.000346	0.00108	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—HPGDS—urinary bladder cancer	0.000346	0.00108	CbGpPWpGaD
Calcitriol—Insomnia—Doxorubicin—urinary bladder cancer	0.000346	0.000771	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000344	0.00108	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000343	0.00108	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—SMC1A—urinary bladder cancer	0.000343	0.00107	CbGpPWpGaD
Calcitriol—Somnolence—Doxorubicin—urinary bladder cancer	0.00034	0.000758	CcSEcCtD
Calcitriol—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000338	0.000753	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—GSTT1—urinary bladder cancer	0.000336	0.00105	CbGpPWpGaD
Calcitriol—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000332	0.000741	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000331	0.00104	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.00033	0.00103	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000329	0.00103	CbGpPWpGaD
Calcitriol—Urticaria—Epirubicin—urinary bladder cancer	0.000328	0.000732	CcSEcCtD
Calcitriol—Pain—Doxorubicin—urinary bladder cancer	0.000327	0.000729	CcSEcCtD
Calcitriol—Constipation—Doxorubicin—urinary bladder cancer	0.000327	0.000729	CcSEcCtD
Calcitriol—Abdominal pain—Epirubicin—urinary bladder cancer	0.000327	0.000728	CcSEcCtD
Calcitriol—Body temperature increased—Epirubicin—urinary bladder cancer	0.000327	0.000728	CcSEcCtD
Calcitriol—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000325	0.000725	CcSEcCtD
Calcitriol—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000324	0.00102	CbGpPWpGaD
Calcitriol—Asthenia—Methotrexate—urinary bladder cancer	0.000317	0.000706	CcSEcCtD
Calcitriol—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000313	0.000697	CcSEcCtD
Calcitriol—Pruritus—Methotrexate—urinary bladder cancer	0.000312	0.000696	CcSEcCtD
Calcitriol—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000304	0.000679	CcSEcCtD
Calcitriol—Urticaria—Doxorubicin—urinary bladder cancer	0.000304	0.000677	CcSEcCtD
Calcitriol—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000302	0.000674	CcSEcCtD
Calcitriol—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000302	0.000674	CcSEcCtD
Calcitriol—Diarrhoea—Methotrexate—urinary bladder cancer	0.000302	0.000673	CcSEcCtD
Calcitriol—VDR—Gene Expression—ESR2—urinary bladder cancer	0.000299	0.000936	CbGpPWpGaD
Calcitriol—Asthenia—Epirubicin—urinary bladder cancer	0.000296	0.000661	CcSEcCtD
Calcitriol—Pruritus—Epirubicin—urinary bladder cancer	0.000292	0.000652	CcSEcCtD
Calcitriol—GC—Metabolism—PPARG—urinary bladder cancer	0.000287	0.0009	CbGpPWpGaD
Calcitriol—Diarrhoea—Epirubicin—urinary bladder cancer	0.000283	0.00063	CcSEcCtD
Calcitriol—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000282	0.000628	CcSEcCtD
Calcitriol—Vomiting—Methotrexate—urinary bladder cancer	0.000281	0.000626	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—NQO1—urinary bladder cancer	0.000279	0.000874	CbGpPWpGaD
Calcitriol—Rash—Methotrexate—urinary bladder cancer	0.000278	0.000621	CcSEcCtD
Calcitriol—Dermatitis—Methotrexate—urinary bladder cancer	0.000278	0.00062	CcSEcCtD
Calcitriol—Headache—Methotrexate—urinary bladder cancer	0.000277	0.000617	CcSEcCtD
Calcitriol—GC—Metabolism—CREBBP—urinary bladder cancer	0.000276	0.000864	CbGpPWpGaD
Calcitriol—Asthenia—Doxorubicin—urinary bladder cancer	0.000274	0.000611	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000271	0.000848	CbGpPWpGaD
Calcitriol—Pruritus—Doxorubicin—urinary bladder cancer	0.00027	0.000603	CcSEcCtD
Calcitriol—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000263	0.000823	CbGpPWpGaD
Calcitriol—Vomiting—Epirubicin—urinary bladder cancer	0.000263	0.000586	CcSEcCtD
Calcitriol—Nausea—Methotrexate—urinary bladder cancer	0.000262	0.000585	CcSEcCtD
Calcitriol—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000262	0.000583	CcSEcCtD
Calcitriol—Rash—Epirubicin—urinary bladder cancer	0.000261	0.000581	CcSEcCtD
Calcitriol—Dermatitis—Epirubicin—urinary bladder cancer	0.00026	0.00058	CcSEcCtD
Calcitriol—Headache—Epirubicin—urinary bladder cancer	0.000259	0.000577	CcSEcCtD
Calcitriol—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000255	0.000798	CbGpPWpGaD
Calcitriol—Nausea—Epirubicin—urinary bladder cancer	0.000245	0.000547	CcSEcCtD
Calcitriol—Vomiting—Doxorubicin—urinary bladder cancer	0.000243	0.000542	CcSEcCtD
Calcitriol—Rash—Doxorubicin—urinary bladder cancer	0.000241	0.000537	CcSEcCtD
Calcitriol—Dermatitis—Doxorubicin—urinary bladder cancer	0.000241	0.000537	CcSEcCtD
Calcitriol—Headache—Doxorubicin—urinary bladder cancer	0.00024	0.000534	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000236	0.00074	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—GSTP1—urinary bladder cancer	0.000233	0.000729	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—NCOR1—urinary bladder cancer	0.000231	0.000722	CbGpPWpGaD
Calcitriol—Nausea—Doxorubicin—urinary bladder cancer	0.000227	0.000506	CcSEcCtD
Calcitriol—GC—Metabolism—PTGS2—urinary bladder cancer	0.000226	0.000708	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000225	0.000706	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—ERCC2—urinary bladder cancer	0.000217	0.000679	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—TYMS—urinary bladder cancer	0.000216	0.000678	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—GSTM1—urinary bladder cancer	0.000214	0.00067	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—NCOR1—urinary bladder cancer	0.000214	0.00067	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—GPX1—urinary bladder cancer	0.000205	0.000642	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—ERCC2—urinary bladder cancer	0.000201	0.00063	CbGpPWpGaD
Calcitriol—GC—Metabolism—PTEN—urinary bladder cancer	0.000197	0.000617	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000196	0.000613	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—MTHFR—urinary bladder cancer	0.000189	0.000592	CbGpPWpGaD
Calcitriol—GC—Metabolism—EP300—urinary bladder cancer	0.000188	0.000589	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—ESR1—urinary bladder cancer	0.000181	0.000567	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000177	0.000553	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000174	0.000546	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—PPARG—urinary bladder cancer	0.000165	0.000518	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.000162	0.000509	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00016	0.000502	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—CREBBP—urinary bladder cancer	0.000159	0.000497	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PPARG—urinary bladder cancer	0.000153	0.00048	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CREBBP—urinary bladder cancer	0.000147	0.000461	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PTGS2—urinary bladder cancer	0.000121	0.000378	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	0.000108	0.000339	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PTEN—urinary bladder cancer	0.000105	0.00033	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	0.000103	0.000321	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—NAT1—urinary bladder cancer	0.000103	0.000321	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—EP300—urinary bladder cancer	0.0001	0.000314	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—MYC—urinary bladder cancer	9.42e-05	0.000295	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	9.38e-05	0.000294	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	8.45e-05	0.000265	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	7.98e-05	0.00025	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	7.77e-05	0.000244	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—TYMP—urinary bladder cancer	6.21e-05	0.000195	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—NAT2—urinary bladder cancer	5.62e-05	0.000176	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—RRM2—urinary bladder cancer	4.85e-05	0.000152	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	4.49e-05	0.000141	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—ENO2—urinary bladder cancer	4.49e-05	0.000141	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	4.36e-05	0.000137	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—NQO1—urinary bladder cancer	3.62e-05	0.000113	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	3.02e-05	9.46e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—TYMS—urinary bladder cancer	2.81e-05	8.8e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	2.78e-05	8.7e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	2.78e-05	8.7e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GPX1—urinary bladder cancer	2.66e-05	8.33e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	2.61e-05	8.18e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	2.45e-05	7.69e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.99e-05	6.23e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.91e-05	5.99e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.56e-05	4.9e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.36e-05	4.28e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.3e-05	4.08e-05	CbGpPWpGaD
